Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.86
-2.40 (-4.27%)
At close: Aug 6, 2026, 4:00 PM EDT
54.60
+0.74 (1.37%)
Pre-market: Aug 7, 2026, 5:54 AM EDT
Moderna Employees
Moderna had 4,700 employees as of December 31, 2025. The number of employees decreased by 1,100 or -18.97% compared to the previous year.
Employees
4,700
Change (1Y)
-1,100
Growth (1Y)
-18.97%
Revenue / Employee
$474,043
Profits / Employee
-$670,426
Market Cap
21.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | -1,100 | -18.97% |
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioNTech SE | 7,807 |
| Genmab | 3,088 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
MRNA News
- 4 hours ago - These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks - Barrons
- 13 hours ago - This new kind of flu shot by Moderna has just been approved by the FDA - Fast Company
- 15 hours ago - Moderna Stock Flashing Intriguing ‘Buy The Dip' Signal - Forbes
- 18 hours ago - Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva - TipRanks
- 21 hours ago - Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future - Barrons
- 23 hours ago - Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market - Barrons
- 1 day ago - Moderna receives FDA approval for mFlusiva in adults 50 years, older - TheFly
- 1 day ago - Moderna Stock (MRNA) Jumps on U.S. Approval for New Flu Shot Type — Why This Matters - TipRanks